FindTrial
Sign In

Cardiovascular Risk in patients with Psoriasis Vulgaris

Cardiovascular Risk in patients with Psoriasis Vulgaris - A Tertiary level hospital based Cross sectional study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/05/053080
Enrollment
41
Registered
2023-05-23
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L400- Psoriasis vulgaris

Interventions

Intervention1: NIL: NIL Intervention2: nil: nil

Sponsors

Dr Reva Batra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Cases of Psoriasis vulgaris over the age of 30 years

Exclusion criteria

Exclusion criteria: 1-Patients with known ischemic heart disease 2-Patients with unstable , guttate, palmoplantar, erythrodermic and pustular psoriasis 3-Patients not willing to participate

Design outcomes

Primary

MeasureTime frame
To screen the patients of psoriasis vulgaris visiting dermatology OPD for cardiovascular(CV)risk factors.Timepoint: Baseline—

Secondary

MeasureTime frame
To correlate the prevalence of various CV risk factors with the disease severity , calculated using PASI scoring (Psoriasis area and severity index)Timepoint: Baseline—

Countries

India

Contacts

Public ContactDr Reva Batra

Kasturba Medical College Manipal MAHE

sb.pai@manipal.edu9900405072

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026